Betahistine or cinnarizine with or without dimenhydrinate for Ménière’s disease/syndrome and symptoms of vestibular vertigo and/or tinnitus
Kanters T, Leeneman B, Oordt A
Record ID 32018013566
English
Original Title:
Treatment with betahistine or cinnarizine with or without dimenhydrinate for adult patients with Ménière’s disease/syndrome and patients experiencing symptoms of vestibular vertigo and/or tinnitus
Details
Project Status:
Ongoing
URL for project:
https://www.bag.admin.ch/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/hta/hta-projekte/betahistin.html
URL for protocol:
https://www.bag.admin.ch/dam/bag/en/dokumente/kuv-leistungen/leistungen-und-tarife/hta/berichte/h0068bhis-hta-protocol.pdf.download.pdf/h0068bhis-hta-protocol.pdf
Anticipated Publish Date:
2025
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Switzerland
MeSH Terms
- Meniere Disease
- Vertigo
- Tinnitus
- Betahistine
- Cinnarizine
- Dimenhydrinate
- Adult
- Drug Therapy
Keywords
- PROMs
- efficacy
- effectiveness
- safety
- costs
- economics
- cost-effectiveness
- budget impact
- legal
- social
- ethical
- organisational
- Betahistine
- cinnarizine
- dimenhydrinate
- Ménière’s disease
- vestibular vertigo
- tinnitus
Contact
Organisation Name:
Swiss Federal Office of Public Health (FOPH)
Contact Address:
Federal Office of Public Health, Schwarzenburgstrasse 157, CH-3003 Berne, Switzerland
Contact Name:
Stephanie Vollenweider
Contact Email:
hta@bag.admin.ch
Copyright:
Swiss Federal Office of Public Health
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.